Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study

Summary

Primary Objective: • To collect post-approval safety data related to intraocular pressure (IOP) after one or more injections of Iluvien as standard of care in subjects with diabetic macular edema (DME). Secondary Objectives: • To collect visual and anatomic outcome data after one or more injections of Iluvien as standard of care in subjects with diabetic macular edema (DME).

Timeline

Start

2017-03-01

Primary completion

2017-08-18

Completion

2017-08-18

Outcome

Outcome not reported

Stopped (Enrollment): “The study was withdrawn due to difficult recruitment of patients for the study; No participants were enrolled in the study.”

Drugs

Indications